Citadel Advisors - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is and the CUSIP is 464330909. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,070,000
-31.1%
51,200
-1.9%
0.00%
-33.3%
Q2 2015$3,004,000
-23.3%
52,200
-15.1%
0.00%
-25.0%
Q1 2015$3,916,000
-1.4%
61,500
-4.4%
0.00%0.0%
Q4 2014$3,970,000
+85.9%
64,300
+16.9%
0.00%
+100.0%
Q3 2014$2,136,000
+80.7%
55,000
+60.3%
0.00%
+100.0%
Q2 2014$1,182,000
-44.0%
34,300
-29.7%
0.00%
-50.0%
Q1 2014$2,109,000
-2.1%
48,800
-9.8%
0.00%
-33.3%
Q4 2013$2,155,000
-10.7%
54,100
-15.9%
0.00%
-25.0%
Q3 2013$2,414,000
+103.2%
64,300
+45.5%
0.00%
+100.0%
Q2 2013$1,188,00044,2000.00%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 124,200$4,948,0000.08%
SABBY MANAGEMENT, LLC 130$518,0000.03%
Timber Hill LLC 82,800$3,299,0000.01%
Citadel Advisors 54,100$2,155,0000.00%
View complete list of ISIS PHARMACEUTICALS INC shareholders